Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vaccinia 1Prostatic Neoplasms 1Oligodendroglioma 1Liver Neoplasms 1Kidney Neoplasms 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

durvalumab 1cemiplimab 1atezolizumab 1Pemetrexed 1Nivolumab 1Granulocyte-Macrophage Colony-Stimulating Factor 1Docetaxel 1Cisplatin 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vaccinia × Granulocyte-Macrophage Colony-Stimulating Factor × 30 days × Clear all
NCT00629759 2026-05-19

A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma

SillaJen, Inc.

Phase 1 Completed
14 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Vaccinia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡